Washington Vertex Pharmaceuticals

FDA Approves 1st Non-Opioid Pain Medicine in 20 Years

FDA approves painkiller designed to eliminate the risk of addiction associated with opioids

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

Axios on MSN · 4d

FDA approves Vertex non-opioid pain drug

The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why it matters: Millions of Americans with acute and chronic pain are prescribed opioids,

CNBC on MSN · 7d

FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.

8don MSN

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)’s Suzetrigine: ‘I Don’t See A Lot Of Upside Because That Was The Drug Of The Future For Vertex’

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Seattle Daily Journal of Commerce11h

Life Science Washington

Life Science Washington, the state’s life sciences industry association, announced the expansion of its board of directors with the ad ...

Washington Times7d

Historic FDA approval marks first nonopioid breakthrough since Clinton era

Sold by Vertex Pharmaceuticals in 50-milligram tablets as Journavx, suzetrigine is the first nonopioid painkiller to target pain-signaling pathways in the peripheral nervous system before those ...

turnto108d

FDA approves painkiller designed to eliminate risks of addiction associated with opioids

WASHINGTON (AP ... The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results